Top compounds associated with response to RLN2


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib GDSC1000 pan-cancer AAC -0.11 0.002
mRNA paclitaxel UHNBreast pan-cancer AAC -0.8 0.002
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Doxorubicin gCSI pan-cancer AAC -0.16 0.003
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA Docetaxel gCSI pan-cancer AAC -0.16 0.003
mRNA Gemcitabine gCSI pan-cancer AAC -0.16 0.004
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.098 0.004
mRNA lapatinib gCSI pan-cancer AAC 0.16 0.004
Download CSV